ConductScience.org, home

Paper37665348

E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia.

Liu Y and 3 others. Ann Hematol, 2023. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia. Papers, record 37665348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37665348

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
E2F1 rs3213150 polymorphism influences cytarabine sensitivity and prognosis in patients with acute myeloid leukemia.
PubMed
Journal
Ann Hematol
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.13
iCite
Revised in PubMed
2023-11-22
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYanfenghttps://orcid.org/0000-0002-2610-3652
2Chen PPeng
3Chen GGe
4Chen XXiaoping

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytarabineMajor topic
Leukemia, Myeloid, AcuteMajor topic
Humans
Remission Induction
Prognosis
Polymorphism, Single Nucleotide
E2F1 Transcription Factor

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2021JJ41011Natural Science Foundation of Hunan ProvincePubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132014868Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges.Cancer Discov2020https://conductscience.org/library/papers/32014868PubMed
231101526Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges.Blood Rev2019https://conductscience.org/library/papers/31101526PubMed
333328603Optimal dosing of cytarabine in induction and post-remission therapy of acute myeloid leukemia.Leukemia2021https://conductscience.org/library/papers/33328603PubMed
427381050Pharmacogenomics and the treatment of acute myeloid leukemia.Pharmacogenomics2016https://conductscience.org/library/papers/27381050PubMed
530088438Comprehensive Ara-C SNP score predicts leukemic cell intracellular ara-CTP levels in pediatric acute myeloid leukemia patients.Pharmacogenomics2018https://conductscience.org/library/papers/30088438PubMed
631950591Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.EMBO Mol Med2020https://conductscience.org/library/papers/31950591PubMed
728068326KLF4 is regulated by RAS/RAF/MEK/ERK signaling through E2F1 and promotes melanoma cell growth.Oncogene2017https://conductscience.org/library/papers/28068326PubMed
833665206E2F1: Cause and Consequence of DNA Replication Stress.Front Mol Biosci2020https://conductscience.org/library/papers/33665206PubMed
928797284Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).J Exp Clin Cancer Res2017https://conductscience.org/library/papers/28797284PubMed
1029631596Association of genetic polymorphisms in genes involved in Ara-C and dNTP metabolism pathway with chemosensitivity and prognosis of adult acute myeloid leukemia (AML).J Transl Med2018https://conductscience.org/library/papers/29631596PubMed
1114673054
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.
J Clin Oncol2003https://conductscience.org/library/papers/14673054PubMed
1229299175Single nucleotide polymorphisms and cancer susceptibility.Oncotarget2017https://conductscience.org/library/papers/29299175PubMed
1326398894Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?Crit Rev Clin Lab Sci2016https://conductscience.org/library/papers/26398894PubMed
1432186770MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.Oncol Rep2020https://conductscience.org/library/papers/32186770PubMed
1532951317Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region.J Cell Mol Med2020https://conductscience.org/library/papers/32951317PubMed
1631870703The conflicting role of E2F1 in prostate cancer: A matter of cell context or interpretational flexibility?Biochim Biophys Acta Rev Cancer2020https://conductscience.org/library/papers/31870703PubMed
1730590814ECT2/PSMD14/PTTG1 axis promotes the proliferation of glioma through stabilizing E2F1.Neuro Oncol2019https://conductscience.org/library/papers/30590814PubMed
1835927248ZNF655 accelerates progression of pancreatic cancer by promoting the binding of E2F1 and CDK1.Oncogenesis2022https://conductscience.org/library/papers/35927248PubMed
198653789Tumor induction and tissue atrophy in mice lacking E2F-1.Cell1996https://conductscience.org/library/papers/8653789PubMed
209774967Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors.Mol Cell1998https://conductscience.org/library/papers/9774967PubMed

See all 36 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
38676765GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy.Ann Hematol2024https://conductscience.org/library/papers/38676765

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
E2F11869PubTator's text mininghttps://conductscience.org/library/genes/1869

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37665348

GET https://conductscience.org/api/papers/v1/37665348/references?page=2